Pulished Date October, 2018
ID: 1076
Share on
Share on

Middle East And Africa Aptamers Market By Type - (Peptide Aptamers, Nucleic Acid Aptamers (DNA-Based Aptamers, RNA-Based Aptamers, And XNA-Based Aptamers)), By Application - (Therapeutics Development, Diagnostics, Research And Development), By End Users - (Pharmaceutical Companies, Bio-Pharmaceutical Companies, Academic And Research Centres) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 1076
Pages: 145

The numerous opportunities offered by the market are the drug discovery, biomarker discovery, and diagnostics segments due to high efficacy of aptamers and doesn’t cause any immunological reactions and low manufacturing cost. They are used as therapeutic tools and biosensors. The effectiveness of aptamers and low cost of manufacturing can provide treatment for diseases like HIV or AIDS to the poorest/low-income countries. The development of aptamers are faster than antibodies which helps to cures the disease faster.

The Middle East and Africa market is driven by low cost of manufacturing, high efficacy of aptamers in binding, advanced technologies, increasing R&D investments in pharmaceutical and biotechnology industries. The restraints that are hindering the growth of the market are Ethical issues for the aptamers that are obtained from animals, stringent regulations in use of aptamers.

Middle East and Africa Aptamers Market was worth $ 13.16 million in 2018 and estimated to reach $ 16.15 million by the end of 2023 with a growing potential of 4.235 %. In the following years, the market is projected to grow enormously with Low cost of manufacturing, high efficacy of aptamers.

The Middle East & Africa Aptamers Market is broadly categorized by type into Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.

Based on Application the market is categorized into Therapeutics Development, Diagnostics, Research and Development and on the basis of end users the market is segmented into Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres and on the basis of geography, the Middle East and Africa Aptamers market is analysed under various regions namely Middle East and Africa.

Major players influencing the Middle East and Africa Aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Aptamers Market By Type, From 2018-2023( USD Billion )
  2. Middle East & Africa Peptide Aptamers Market By Region, From 2018-2023( USD Billion )
  3. Middle East & Africa Nucleic Acid Aptamers Market By Region, From 2018-2023( USD Billion )
  4. Middle East & Africa Aptamers Market By Application, From 2018-2023( USD Billion )
  5. Middle East & Africa Therapeutics Development Market By Region, From 2018-2023( USD Billion )
  6. Middle East & Africa Diagnostics Market By Region, From 2018-2023( USD Billion )
  7. Middle East & Africa Research and Development Market By Region, From 2018-2023( USD Billion )
  8. Middle East & Africa Aptamers Market By End users, From 2018-2023( USD Billion )
  9. Middle East & Africa Pharmaceutical Companies Market By Region, From 2018-2023( USD Billion )
  10. Middle East & Africa Bio-Pharmaceutical Companies Market By Region, From 2018-2023( USD Billion )
  11. Middle East & Africa Academic and Rsearch centers Market By Region, From 2018-2023( USD Billion )
  12. Middle East Aptamers Market By Type, From 2018-2023( USD Billion )
  13. Middle East Aptamers Market By Application, From 2018-2023( USD Billion )
  14. Middle East Aptamers Market By End users, From 2018-2023( USD Billion )
  15. Africa Aptamers Market By Type, From 2018-2023( USD Billion )
  16. Africa Aptamers Market By Application, From 2018-2023( USD Billion )
  17. Africa Aptamers Market By End users, From 2018-2023( USD Billion )
  18. Middle East & Africa Aptamers Market By Nucleic Acid Aptamers, From 2018-2023( USD Billion )
  19. Middle East & Africa DNA Based Aptamers Market By Region, From 2018-2023( USD Billion )
  20. Middle East & Africa RNA Based Aptamers Market By Region, From 2018-2023( USD Billion )
  21. Middle East & Africa XNA Based Aptamers Market By Region, From 2018-2023( USD Billion )
  22. Middle East Aptamers Market By Nucleic Acid Aptamers, From 2018-2023( USD Billion )
  23. Africa Aptamers Market By Nucleic Acid Aptamers, From 2018-2023( USD Billion )

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients